Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

This meta-analysis evaluated the 10-year outcomes of the TROG 03.04 RADAR trial, which compared 6 months versus 18 months of androgen suppression (AS) combined with radiotherapy (RT), with or without zoledronic acid (ZA), in men with locally advanced prostate cancer. The study found that extending AS to 18 months significantly